Mohamed-Eslam Mohamed, PhD

AbbVie
North Chicago, IL, United States

Dr. Mohamed is Director of Clinical Pharmacology and Pharmacometrics at AbbVie. He earned his PhD in Clinical Pharmaceutical Sciences from the University of Florida College of Pharmacy in 2010 where he later completed a post-doctoral fellowship. Dr. Mohamed earned his Bachelor’s degree in pharmacy from Ain Shams University in Cairo, Egypt. He has been working at AbbVie since 2013 where he supports the development of new drugs for the treatment of autoimmune disorders, including rheumatologic, gastrointestinal, and dermatologic autoimmune diseases. Dr. Mohamed has co-authored over 80 publications spanning the fields of clinical pharmacology and immunology including several manuscripts in leading medical and clinical pharmacology journals. Dr. Mohamed is a Fellow of the American College of Clinical Pharmacology.

Disclosure information not submitted.

Presentation(s):

• 0300: Exposure-Response Analyses of Upadacitinib Effects on Plasma Biomarkers in Rheumatoid Arthritis Patients

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time

• 0425: Upadacitinib Pharmacokinetics and Exposure-Response Relationships for Efficacy and Safety in Axial Spondyloarthritis – Analyses of the Phase 3 Studies (SELECT-AXIS 1 and 2)

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time